Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

541.69
-5.8600-1.07%
Post-market: 541.15-0.5400-0.10%19:58 EDT
Volume:886.92K
Turnover:481.13M
Market Cap:137.44B
PE:31.53
High:549.57
Open:547.09
Low:540.08
Close:547.55
52wk High:555.69
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.03
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.79
PE(LYR):35.36

Loading ...

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $633 from $610

THOMSON REUTERS
·
Aug 11

Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers

Dow Jones
·
Aug 11

U.S. Stocks on the MOVE-Microsoft, Coastal Financial

Reuters
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals price target raised to $672 from $605 at BofA

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals jumps 7% after rival's drug trial fails to meet key goals

Stock News
·
Aug 10

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-10

Reuters
·
Aug 10

Early notable gainers among liquid option names on August 10th

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Movement Alert|Vertex Pharmaceuticals Rises 9.21% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 10

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS
·
Aug 10

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Reuters
·
Aug 10

Movement Alert|Vertex Pharmaceuticals Rises 3.26% in Pre-Market Trading, Q2 Earnings Beat Expectations as Multiple Firms Raise Price Targets

Market Focus
·
Aug 10

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

TIPRANKS
·
Aug 07

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

TIPRANKS
·
Aug 06

Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays

TIPRANKS
·
Aug 05